Scientists probe Brain's inner wiring to unlock depression treatment secrets
NCT ID NCT07560878
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study aims to understand how a specific type of brain stimulation, called continuous theta-burst stimulation (cTBS), affects brain activity in people with depression. Researchers will give participants a single dose of one of four FDA-approved drugs (or a placebo) that either boost or block key brain chemicals, then measure brain responses with EEG. The goal is to figure out whether cTBS works by weakening overactive connections or by strengthening the brain's natural braking system. This knowledge could lead to more personalized and effective treatments for depression.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
McLean Hospital
RECRUITINGBelmont, Massachusetts, 02478, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain wave clues: could inflammation markers forecast ECT outcomes?
- Brain scans may guide psychedelics and magnetic pulses to quell suicidal thoughts
- A headset for depression in pregnancy โ science tests a Drug-Free option
- Can a common supplement lift depression and sharpen memory in seniors?
- Can pulling an all-nighter reveal how depression hijacks sleep and mood?
- Could a probiotic boost antidepressants? new trial tests Gut-Brain mood link